Supporting the findings of this study, a recent study done by Park et al. (102) revealed a unique expression of FOXA2 in PCa tumor microarrays of primary small cell NEPC as well as treatment-related CRPC-NE tumors (102). This evidence concerns the gene FOXA2 and posterior cortical atrophy.